540H:F:F-Amundi ETF MSCI Europe Ex EMU UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 378.6

Change

-1.10 (-0.29)%

Market Cap

USD 0.21B

Volume

2.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.74 (-1.42%)

USD 128.40B
SXR8:F iShares Core S&P 500 UCITS ETF..

-13.56 (-2.41%)

USD 114.04B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.79 (-1.38%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.23 (-1.47%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 53.72B
SXRZ:F iShares VII PLC - iShares Nikk..

-3.60 (-1.55%)

USD 52.44B
VUSA:F Vanguard Funds Public Limited ..

-1.29 (-1.30%)

USD 51.63B
0ZC:F Zscaler Inc

-3.30 (-1.48%)

USD 37.92B
BSND:F Danone SA

+0.20 (+1.39%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-1.66 (-1.29%)

USD 24.77B

ETFs Containing 540H:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.93% 74% C 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.93% 74% C 66% D+
Trailing 12 Months  
Capital Gain 4.15% 54% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.15% 51% F 53% F
Trailing 5 Years  
Capital Gain 68.23% 65% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 68.23% 65% D 48% F
Average Annual (5 Year Horizon)  
Capital Gain 10.99% 74% C 68% D+
Dividend Return 10.99% 72% C 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.69% 68% D+ 92% A
Risk Adjusted Return 113.36% 97% N/A 96% N/A
Market Capitalization 0.21B 43% F 38% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.